• Stock declines over 8% after recent strong rally
  • Profit booking emerges near higher trading levels
  • Momentum cools after extended upward move

Overview

Sakar Healthcare Ltd (NSE: SAKAR) is trading near ₹577.25, down 8.32% in the session, after witnessing sharp selling pressure near recent highs. The stock had rallied strongly over the past several weeks and recently approached the ₹640.00 zone before profit booking emerged.

Despite the decline, the broader trend remains positive as the stock continues to trade above its 50-day SMA near ₹554.18. The correction appears linked to near-term consolidation and cautious sentiment after the sharp rally rather than any major deterioration in fundamentals.

Fundamental View

For the quarter ended December 2025, Sakar Healthcare Ltd reported standalone total income of ₹7,085.01 lakh. Profit before tax stood at ₹1,095.24 lakh, while net profit came in at ₹1,024.90 lakh. Earnings per share for the quarter was reported at ₹4.59.

The company’s financial performance remained stable, reflecting continued operational strength. However, after the stock’s significant rally over recent months, investors appear to be turning cautious at elevated levels. Market participants may also be reassessing valuations after the sharp upward move.

The stock has also seen strong gains over the past year, which increases the possibility of intermittent profit booking phases.

Technical View

Technically, SAKAR remains above its 50-day SMA, indicating that the broader structure is still constructive. However, the stock faced selling pressure after failing to sustain momentum near recent highs around ₹640.00.

The 14-day RSI has cooled to around 47.01 after previously remaining in a stronger momentum zone, suggesting that short-term momentum has weakened sharply. Price action indicates that traders may now wait for stability before fresh positioning.

The recent decline also reflects increased volatility after the extended rally.

Key Technical Levels

Immediate support is placed near ₹530.00–₹500.00, which could act as an important zone on further weakness. On the upside, resistance is seen around ₹615.00–₹645.00, where the stock may again face selling pressure.

Risks

• Profit booking after sharp rally
  • Increased near-term volatility
  • Valuation concerns at higher levels
  • Weakening short-term momentum

Summary

Sakar Healthcare Ltd (NSE: SAKAR) corrected sharply after a strong multi-week rally, with investors appearing cautious near higher trading levels. While the company’s earnings performance remained stable, the stock’s rapid rise may have triggered profit booking and short-term consolidation.

The broader structure remains positive above the 50-day SMA, but traders will closely monitor whether the stock stabilizes near support zones or witnesses further volatility in the near term.

FAQs

Why did SAKAR share price fall today?
The decline appears linked to profit booking after the stock’s recent strong rally toward fresh highs.

What were Sakar Healthcare’s latest quarterly numbers?
The company reported total income of ₹7,085.01 lakh and net profit of ₹1,024.90 lakh for the December 2025 quarter.

What are the important levels to watch in SAKAR?
Support is placed near ₹530.00–₹500.00, while resistance is seen around ₹615.00–₹645.00.